Application

W WELLS PHARMA LLC END TO END GLOBAL SERVICES

Khan, Ragonot

Trademark/Service Mark Application, Principal Register

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

Serial Number: 90254808
Filing Date: 10/14/2020

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 90254808
MARK INFORMATION
*MARK \\TICRS\EXPORT18\IMAGEOUT 18\902\548\90254808\xml1 \ APP0002.JPG
SPECIAL FORM YES
USPTO-GENERATED IMAGE NO
LITERAL ELEMENT w wells pharma llc end to end global services
COLOR MARK YES
COLOR(S) CLAIMED
(If applicable)
The color(s) red, red, and black is/are claimed as a feature of the mark.
*DESCRIPTION OF THE MARK
(and Color Location, if applicable)
The mark consists of centered, red letter: W centered red letters, company name: Wells Pharma LLC centered black letters, phrase: END TO END GLOBAL SERVICES.
PIXEL COUNT ACCEPTABLE YES
PIXEL COUNT 250 x 375
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Khan, Ragonot
*MAILING ADDRESS 107-23 Jamaica Avenue
*CITY Richmond Hill
*STATE
(Required for U.S. applicants)
New York
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
11418
*DOMICILE XXXX
PHONE 646-645-3632
*EMAIL ADDRESS XXXX
LEGAL ENTITY INFORMATION
TYPE limited liability company
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY WHERE LEGALLY ORGANIZED New York
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 035 
*IDENTIFICATION Providing advertising, marketing and promotional services for the pharmaceutical and medical industry
FILING BASIS SECTION 1(b)
INTERNATIONAL CLASS 042 
*IDENTIFICATION Pharmaceutical research and development
FILING BASIS SECTION 1(b)
CORRESPONDENCE INFORMATION
NAME Khan, Ragonot
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE BD@Wellspharma.us
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) suraj@1040pros.net
FEE INFORMATION
APPLICATION FILING OPTION TEAS Standard
NUMBER OF CLASSES 2
APPLICATION FOR REGISTRATION PER CLASS 275
*TOTAL FEES DUE 550
*TOTAL FEES PAID 275
SIGNATURE INFORMATION
SIGNATURE /Ragonot Khan/
SIGNATORY'S NAME Ragonot Khan
SIGNATORY'S POSITION owner/ holder
SIGNATORY'S PHONE NUMBER 646-645-3632
DATE SIGNED 10/14/2020



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)


Trademark/Service Mark Application, Principal Register

Serial Number: 90254808
Filing Date: 10/14/2020

To the Commissioner for Trademarks:

MARK: w wells pharma llc end to end global services (stylized and/or with design, see mark)
The literal element of the mark consists of w wells pharma llc end to end global services. The color(s) red, red, and black is/are claimed as a feature of the mark. The mark consists of centered, red letter: W centered red letters, company name: Wells Pharma LLC centered black letters, phrase: END TO END GLOBAL SERVICES.
The applicant, Khan, Ragonot, a limited liability company legally organized under the laws of New York, having an address of
      107-23 Jamaica Avenue
      Richmond Hill, New York 11418
      United States
      646-645-3632(phone)
      XXXX
Domiciled at: XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

For specific filing basis information for each item, you must view the display within the Input Table.
International Class 035:  Providing advertising, marketing and promotional services for the pharmaceutical and medical industry
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

For specific filing basis information for each item, you must view the display within the Input Table.
International Class 042:  Pharmaceutical research and development
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.




The applicant's current Correspondence Information:
      Khan, Ragonot
       PRIMARY EMAIL FOR CORRESPONDENCE: BD@Wellspharma.us
       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): suraj@1040pros.net


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $275 has been submitted with the application, representing payment for 1 class(es).

Declaration

Declaration Signature

Signature: /Ragonot Khan/   Date: 10/14/2020
Signatory's Name: Ragonot Khan
Signatory's Position: owner/ holder
Payment Sale Number: 90254808
Payment Accounting Date: 10/14/2020

Serial Number: 90254808
Internet Transmission Date: Wed Oct 14 16:12:10 ET 2020
TEAS Stamp: USPTO/BAS-XX.XXX.XX.XX-20201014161210612
083-90254808-750304dc620f36758ecdd845aad
8f396b12b3a537f3885ec8f9cdaca02010b65b-C
C-12095477-20201014132927637967

Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed